In colitis-associated colorectal cancer, GSDME-mediated pyroptosis promotes tumorigenesis through the release of HMGB1, which subsequently activates the ERK1/2 pathway to drive tumor cell proliferation [186]. Here, HMGB1 is linked to neoplasm.